The microbiota and immune system crosstalk in health and disease

Mediators of Inflammation

Volumn 2018, Issue , 2018, Pages

  Cianci, Rossella ^a   Pagliari, Danilo ^a   Piccirillo, Ciriaco A ^b   Fritz, Jörg H ^c   Gambassi, Giovanni ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; COLCHICINE; CYTOKINE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; RIFAXIMIN; SECRETORY IMMUNOGLOBULIN; TOLL LIKE RECEPTOR; XENOBIOTIC AGENT;

ACNE VULGARIS; ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; BACTERIAL COLONIZATION; COMMENSAL; DIABETES MELLITUS; DISEASES; DYSBIOSIS; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; INFECTIOUS AGENT; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; INTESTINE FLORA; INTESTINE MUCOSA; LIPID DIET; LIVER DISEASE; METABOLIC SYNDROME X; MICROFLORA; NONALCOHOLIC FATTY LIVER; NONALCOHOLIC STEATOHEPATITIS; NONHUMAN; OBESITY; PANCREAS CANCER; PANCREAS DISEASE; PANCREATITIS; REVIEW; RISK FACTOR; SKIN FLORA; T LYMPHOCYTE SUBPOPULATION; ANIMAL; GENETICS; MICROBIOLOGY; PHYSIOLOGY;

ANIMALS; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNE SYSTEM; MICROBIOTA;

EID: 85055655553     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2018/2912539     Document Type: Review

References (14)

1. E. Thursby and N. Juge, “Introduction to the human gut microbiota,” Biochemical Journal, vol. 474, no. 11, pp. 1823–1836, 2017.
2. M. Y. Zeng, N. Inohara, and G. Nunez, “Mechanisms of inflammation-driven bacterial dysbiosis in the gut,” Mucosal Immunology, vol. 10, no. 1, pp. 18–26, 2017.
3. L. Yurkovetskiy, M. Burrows, A. A. Khan et al., “Gender bias in autoimmunity is influenced by microbiota,” Immunity, vol. 39, no. 2, pp. 400–412, 2013.
4. A. Paun, C. Yau, and J. S. Danska, “The influence of the microbiome on type 1 diabetes,” The Journal of Immunology, vol. 198, no. 2, pp. 590–595, 2017.
5. J. J. Faith, J. L. Guruge, M. Charbonneau et al., “The long-term stability of the human gut microbiota,” Science, vol. 341, no. 6141, article 1237439, 2013.
6. D. Statovci, M. Aguilera, J. MacSharry, and S. Melgar, “The impact of Western diet and nutrients on the microbiota and immune response at mucosal interfaces,” Frontiers in Immunology, vol. 8, p. 838, 2017.
7. C. A. Thaiss, M. Levy, T. Korem et al., “Microbiota diurnal rhythmicity programs host transcriptome oscillations,” Cell, vol. 167, no. 6, pp. 1495–1510.e12, 2016.
8. A. K. Fleck, D. Schuppan, H. Wiendl, and L. Klotz, “Gut–CNS-axis as possibility to modulate inflammatory disease activity—implications for multiple sclerosis,” International Journal of Molecular Sciences, vol. 18, no. 7, p. 1526, 2017.
9. D. Pagliari, C. A. Piccirillo, A. Larbi, and R. Cianci, “The interactions between innate immunity and microbiota in gastrointestinal diseases,” Journal of Immunology Research, vol. 2015, Article ID 898297, 3 pages, 2015.
10. R. Cianci, D. Pagliari, V. Pietroni, R. Landolfi, and F. Pandolfi, “Tissue infiltrating lymphocytes: the role of cytokines in their growth and differentiation,” Journal of Biological Regulators and Homeostatic Agents, vol. 24, no. 3, pp. 239–249, 2010.
11. J. M. Blander, R. S. Longman, I. D. Iliev, G. F. Sonnenberg, and D. Artis, “Regulation of inflammation by microbiota interactions with the host,” Nature Immunology, vol. 18, no. 8, pp. 851–860, 2017.
12. F. Sommer, M. C. Rühlemann, C. Bang et al., “Microbiomarkers in inflammatory bowel diseases: caveats come with caviar,” Gut, vol. 66, no. 10, pp. 1734–1738, 2017.
13. T. Yamashita, “Intestinal immunity and gut microbiota in atherogenesis,” Journal of Atherosclerosis and Thrombosis, vol. 24, no. 2, pp. 110–119, 2017.
14. J. C. Arthur, E. Perez-Chanona, M. Muhlbauer et al., “Intestinal inflammation targets cancer-inducing activity of the microbiota,” Science, vol. 338, no. 6103, pp. 120–123, 2012.